Company Filing History:
Years Active: 2003-2007
Title: The Innovative Contributions of Susan Hama in Atherosclerosis Research
Introduction
Susan Hama, an accomplished inventor based in Torrance, California, has made significant strides in the field of medical diagnostics with her innovative research. With a total of three patents to her name, her work focuses primarily on the role of high-density lipoprotein (HDL) in relation to atherosclerosis, a major health concern globally.
Latest Patents
Among her notable patents, Susan Hama developed a functional assay of high-density lipoprotein. This invention is groundbreaking as it provides novel assays that are prognostic and diagnostic for atherosclerosis or the risk of developing it. Her research uncovered that HDL or its components can inhibit the oxidation of lipids present in low-density lipoproteins (LDLs) and can also aid in the repair of already oxidized lipids. This mechanism plays a crucial role in reducing the inflammatory response associated with the formation of atherosclerotic plaques. Moreover, Hama's findings demonstrate that the protective ability of HDL can vary significantly among individuals, making her assays vital for assessing the risk of atherosclerosis and its related conditions.
Career Highlights
Susan Hama is associated with the University of California, where she continues to contribute to medical research and innovation. Her work has garnered attention for its potential to enhance diagnostic methodologies and improve patient outcomes in cardiology.
Collaborations
Throughout her career, Susan has collaborated with esteemed colleagues in the field, including Alan M. Fogelman and Mohamad Navab. These partnerships have further enriched her research endeavors and have played a crucial role in advancing her innovative projects.
Conclusion
In summary, Susan Hama exemplifies the spirit of innovation in the medical research landscape. Her contributions, particularly in understanding the role of HDL in preventing atherosclerosis, not only enhance our diagnostic capabilities but also pave the way for future advancements in the treatment and management of cardiovascular diseases. Her ongoing work at the University of California represents a commitment to innovation that could profoundly impact public health.